Indo MIM files DRHP for ₹400 crore IPO to repay debt

3 min read     Updated on 21 Jul 2026, 11:53 AM
scanx
Reviewed by
Shraddha JScanX News Team
AI Summary

Indo MIM Limited has filed its DRHP for a ₹400 crore fresh issue IPO aimed at debt repayment. The global leader in Metal Injection Molding reported a PAT of ₹533.54 crore in FY2026 and holds a 6.8% global market share. The IPO opens on July 23, 2026, and closes on July 27, 2026.

powered bylight_fuzz_icon
46160573

*this image is generated using AI for illustrative purposes only.

Indo MIM Limited, the world's largest manufacturer of Metal Injection Molding (MIM) components, has filed its Draft Red Herring Prospectus (DRHP) with market regulators to raise funds through an Initial Public Offering (IPO). The company aims to utilize the net proceeds, estimated at ₹400 crore via a fresh issue, primarily for the repayment or prepayment of outstanding borrowings availed from banks and financial institutions. This strategic move is intended to reduce the company's indebtedness and maintain a favorable debt-equity ratio, potentially strengthening its balance sheet for future growth.

Financial Performance and Growth

Indo MIM has demonstrated robust financial momentum in the years leading up to its public offering. Revenue from operations grew from ₹2,870.40 crore in FY2024 to ₹4,192.98 crore in FY2026, representing a cumulative increase of approximately 46.1% over two years. This growth trajectory accelerated with a 25.93% year-on-year rise in FY2026, up from 16.00% in the previous year.

Profitability has also expanded significantly. The company's total profit, or Profit After Tax (PAT), nearly doubled from ₹283.73 crore in FY2024 to ₹533.54 crore in FY2026. This performance was supported by strong operational leverage, as evidenced by the PAT margin improving to 12.72% relative to revenue from operations in FY2026. Additionally, the company reported a positive turnaround in net cash flow, which reached ₹214.94 crore in FY2026, driven by operating cash flows that nearly doubled to ₹1,077.24 crore.

Operational Scale and Market Position

The company's operational capabilities are underpinned by its status as the global leader in the MIM sector, a position it has maintained for six consecutive years with a 6.8% global market share as of Calendar Year 2025. Indo MIM operates 15 manufacturing facilities across India, the United States, the United Kingdom, and Mexico, leveraging a dual-shore model to combine cost efficiency with proximity to key global markets.

Key Operational Metrics (FY2026) Value
Global MIM Market Share 6.80%
Manufacturing Facilities 15
Product Types Manufactured 9,000+
Robots Deployed 436
IoT-Enabled Machines 476
Permanent Employees in India 4,424

The company serves a diversified portfolio of sectors including automotive, defence, medical devices, consumer durables, and aerospace. Its global footprint is further emphasized by export revenue, which accounted for 77.20% of total revenue in FY2026. Customer stickiness remains a strong point, with repeat customers contributing 91.60% of revenue from operations in the same year.

IPO Structure and Timeline

The IPO consists entirely of a fresh issue of ₹400 crore, with no Offer for Sale (OFS) component included in the current draft. While the price band and face value are yet to be announced, the company has outlined a tentative schedule for the issue. The IPO is set to open on July 23, 2026, and close on July 27, 2026. Allotment of shares is expected to be finalized on July 28, 2026, with listing scheduled for July 30, 2026.

Risk Factors and Governance

Despite its strong market position, Indo MIM faces several risks that potential investors must consider. The company exhibits a high dependency on exports, with the majority of its revenue generated outside India, exposing it to geopolitical tensions and currency fluctuations. Furthermore, it operates largely on a purchase order basis without definitive long-term agreements, which creates uncertainty regarding future demand visibility.

A noteworthy governance risk highlighted in the DRHP involves show cause notices issued to the company's Promoters, Directors, and Key Managerial Personnel (KMPs) regarding alleged non-compliance with mandatory cost auditor appointment requirements. Additionally, the company relies heavily on imported raw materials, which constituted 60.95% of total raw material procurement in FY2026, adding a layer of supply chain and cost volatility.

How will the reduction of debt through IPO proceeds impact Indo MIM's ability to fund future capital expenditures and technological upgrades?

What strategies will the company employ to mitigate risks associated with currency fluctuations given that 77.20% of revenue comes from exports?

How might the lack of long-term definitive agreements with customers affect revenue stability and investor confidence post-IPO?

like17
dislike